EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Therapeutic potency of A1 adenosine receptor antagonists in the treatment of cardiovascular diseases, current status and perspectives

Amirhossein Bahreyni, Nikoo Saeedi, Abdulridha Mohammed Al-Asady, Atena Soleimani, Elnaz Ghorbani, Majid Khazaei, Maryam Alaei, Reyhane Hanaei, Mikhail Ryzhikov, Amir Avan, Seyed Mahdi Hassanian

Molecular Biology Reports · 2024

DOI: 10.1007/s11033-024-09246-6 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Biology Reports, 2024. Verfasst von Amirhossein Bahreyni und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Hauptthemen laut MEDLINE: Purinergic P1 Receptor Antagonists, Cardiovascular Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: National Institute for Medical Research Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Cardiomyocytes form, transport, and metabolize the omnipresent metabolite adenosine. Depending upon the adenosine concentrations and the pharmacological properties of receptor subtypes, adenosine exerts (patho)physiological responses in the cardiovascular system. The objective of this review is to present different protective mechanisms of A1-adenosine receptor inhibitors in cardiovascular diseases. METHODS AND RESULTS: Literature references were collected and sorted using relevant keywords and key phrases as search terms in scientific databases such as Web of Science, PubMed and Google Scholar. A1 adenosine receptor regulates free fatty acid metabolism, lipolysis, heart rate, blood pressure, and cardiovascular toxicity. The evidence clearly supporting the therapeutic potency of pharmacological A1 adenosine receptors agonists and antagonists in modulating cardiovascular risk factor parameters and treatment of cardiovascular diseases. CONCLUSION: This review summarizes the protective role of pharmacological A1-adenosine receptor regulators in the pathogenesis of cardiovascular diseases for a better management of cardiovascular diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Purinergic P1 Receptor AntagonistsCardiovascular DiseasesHumansBlood PressureAdenosineReceptors, Purinergic P1

Stichwörter der Autor:innen

A1 adenosine receptorCardiovascular diseasesPharmacological inhibitors

Substanzen

Purinergic P1 Receptor AntagonistsAdenosineReceptors, Purinergic P1

Autor:innen und Institutionen

  • Department of Clinical Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Student Research Committee, Islamic Azad University, Mashhad Branch, Mashhad, Iran.
  • Department of Medical Sciences, Faculty of Nursing, University of Warith Al-Anbiyaa, Karbala, Iraq.
  • Department of pharmacology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Department of Medical Sciences, Faculty of Dentistry, University of Kerbala, Karbala, Iraq.
  • Department of Medical Microbiology and virology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Förderung

  • National Institute for Medical Research Development

Zitieren

APA

Bahreyni, A., Saeedi, N., Al-Asady, A. M., Soleimani, A., Ghorbani, E., Khazaei, M., Alaei, M., Hanaei, R., Ryzhikov, M., Avan, A., & Hassanian, S. M. (2024). Therapeutic potency of A1 adenosine receptor antagonists in the treatment of cardiovascular diseases, current status and perspectives. Molecular Biology Reports. https://doi.org/10.1007/s11033-024-09246-6

Vancouver

Bahreyni A, Saeedi N, Al-Asady AM, Soleimani A, Ghorbani E, Khazaei M, et al. Therapeutic potency of A1 adenosine receptor antagonists in the treatment of cardiovascular diseases, current status and perspectives. Molecular Biology Reports. 2024. doi:10.1007/s11033-024-09246-6

BibTeX
@article{Bahreyni2024,
  author = {Bahreyni, Amirhossein and Saeedi, Nikoo and Al-Asady, Abdulridha Mohammed and Soleimani, Atena and Ghorbani, Elnaz and Khazaei, Majid and Alaei, Maryam and Hanaei, Reyhane and Ryzhikov, Mikhail and Avan, Amir and Hassanian, Seyed Mahdi},
  title = {Therapeutic potency of A1 adenosine receptor antagonists in the treatment of cardiovascular diseases, current status and perspectives},
  journal = {Molecular Biology Reports},
  year = {2024},
  doi = {10.1007/s11033-024-09246-6}
}
Kostenlos starten →